Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with genetically defined diseases.
Stock is 

SEC Filings

Filing date Form Description Filing Group View
REGDEX

REGDEX

Other
View HTML
D
Other
View HTML
D
Other
View HTML
DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Registration Statements
View HTML
S-1

Registration statement for face-amount certificate companies

Registration Statements
View HTML
UPLOAD

UPLOAD

Other
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
CORRESP

CORRESP

Other
View HTML
UPLOAD

UPLOAD

Other
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML